Expression and prognostic significance of hypoxia-inducible factor 1α (HIF-1α) in malignant pleural mesothelioma (MPM)

被引:47
|
作者
Klabatsa, A [1 ]
Sheaff, MT
Steele, JPC
Evans, MT
Rudd, RM
Fennell, DA
机构
[1] Royal London Hosp, Inst Pathol, Queen Mary Sch Med & Dent, London E1 1BB, England
[2] Univ London St Bartholomews Hosp Med Coll, Dept Med Oncol, Queen Marys Sch Med & Dent, London EC1A 7BE, England
[3] Belfast City Hosp, No Ireland Thorac Oncol Res Grp, Ctr Canc Res, Belfast BT9 7AD, Antrim, North Ireland
关键词
hypoxia-inducible factor 1 alpha (HIF-1 alpha); malignant pleural mesothelioma (MPM); hypoxia; apoptosis; microvessel density (MVD); angiogenesis;
D O I
10.1016/j.lungcan.2005.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant pleural mesothelioma (MPM) is a highly chemoresistant cancer with a poor prognosis. Hypoxia is a specific property of solid tumours, contributes to tow apoptotic potential, and can be selectively targeted by bioreductive drugs. Hypoxia-inducible factor 1 alpha (HIF-1 alpha) is a subunit of a heterodimeric transcription complex that regulates several genes associated with tumour progression and antiapoptosis. In this study, we measured for the first time the expression of HIF-1 alpha in MPM. Our results show that HIF-1 alpha is commonly expressed in MPM but not in normal mesothelium, consistent with the presence of hypoxia. HIF-1 alpha does not appear to predict survival; however, this study suggests that bioreductive drugs should be investigated in clinical trials of MPM. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:53 / 59
页数:7
相关论文
共 50 条
  • [1] Expression and prognostic significance of hypoxia-inducible factor 1 alpha in malignant pleural mesothelioma
    Klabatsa, A
    Fennell, DA
    Evans, MT
    Shamash, J
    Steele, JPC
    Rudd, RM
    Sheaff, MT
    JOURNAL OF PATHOLOGY, 2003, 201 : 49A - 49A
  • [2] Hypoxia-inducible factor-1 (HIF-1)
    Schumacker, PT
    CRITICAL CARE MEDICINE, 2005, 33 (12) : S423 - S425
  • [3] Hypoxia-inducible factor-1 (HIF-1)
    Ke, Qingdong
    Costa, Max
    MOLECULAR PHARMACOLOGY, 2006, 70 (05) : 1469 - 1480
  • [4] Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer
    Isobe, Taro
    Aoyagi, Keishiro
    Koufuji, Kikuo
    Shirouzu, Kazuo
    Kawahara, Akihiro
    Taira, Tomoki
    Kage, Masayoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (02) : 293 - 304
  • [5] CLINICOPATHOLOGICAL SIGNIFICANCE OF HYPOXIA-INDUCIBLE FACTOR-1 ALPHA (HIF-1α) EXPRESSION IN GASTRIC CANCER
    Isobe, T.
    Aoyagi, K.
    Hashimoto, K.
    Kizaki, J.
    Miyagi, M.
    Koufuji, K.
    Sasatomi, T.
    Shirouzu, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 248 - 249
  • [6] Clinicopathological significance of hypoxia-inducible factor-1 alpha (HIF-1α) expression in gastric cancer
    Taro Isobe
    Keishiro Aoyagi
    Kikuo Koufuji
    Kazuo Shirouzu
    Akihiro Kawahara
    Tomoki Taira
    Masayoshi Kage
    International Journal of Clinical Oncology, 2013, 18 : 293 - 304
  • [7] Expression of hypoxia-inducible factor-1α (HIF-1α) in pituitary tumours
    Vidal, S
    Horvath, E
    Kovacs, K
    Kuroki, T
    Lloyd, RV
    Scheithauer, BW
    HISTOLOGY AND HISTOPATHOLOGY, 2003, 18 (03) : 679 - 686
  • [8] HIF-1:: hypoxia-inducible factor or dysoxia-inducible factor?
    Lopez-Lazaro, Miguel
    FASEB JOURNAL, 2006, 20 (07): : 828 - 832
  • [9] Glucocorticoids inhibit hypoxia-inducible factor 1 (HIF-1)
    Wagner, AE
    Hellwig-Buergel, T
    Stiehl, DP
    Jelkmann, W
    FASEB JOURNAL, 2005, 19 (05): : A1603 - A1603
  • [10] Hypoxia-inducible factor I (HIF-1) in cancer
    Quintero, M
    Mackenzie, N
    Brennan, PA
    EJSO, 2004, 30 (05): : 465 - 468